IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 192 filers reported holding IMMUNOGEN INC in Q2 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $441,932 | -76.7% | 27,847 | -72.3% | 0.00% | -80.0% |
Q2 2023 | $1,897,680 | +2008.5% | 100,566 | +432.1% | 0.01% | – |
Q1 2022 | $90,000 | -85.3% | 18,900 | -77.1% | 0.00% | -100.0% |
Q4 2021 | $612,000 | +292.3% | 82,485 | +170.0% | 0.00% | +100.0% |
Q4 2019 | $156,000 | -38.1% | 30,553 | -70.7% | 0.00% | -50.0% |
Q3 2019 | $252,000 | +327.1% | 104,167 | +286.1% | 0.00% | +100.0% |
Q2 2019 | $59,000 | -3.3% | 26,979 | +111.6% | 0.00% | – |
Q4 2018 | $61,000 | +335.7% | 12,750 | +750.0% | 0.00% | – |
Q3 2018 | $14,000 | -96.6% | 1,500 | -96.2% | 0.00% | -100.0% |
Q1 2018 | $412,000 | +858.1% | 39,200 | +256.4% | 0.00% | – |
Q1 2017 | $43,000 | -74.3% | 11,000 | -86.6% | 0.00% | -100.0% |
Q4 2016 | $167,000 | +5466.7% | 82,000 | +6207.7% | 0.00% | – |
Q3 2016 | $3,000 | -97.9% | 1,300 | -87.7% | 0.00% | -100.0% |
Q4 2015 | $143,000 | +2760.0% | 10,558 | +2011.6% | 0.00% | – |
Q3 2015 | $5,000 | +66.7% | 500 | +150.0% | 0.00% | – |
Q2 2015 | $3,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TWIN FOCUS CAPITAL PARTNERS, LLC | 140,000 | $2,090,000 | 2.48% |
BB BIOTECH AG | 3,165,816 | $47,266,000 | 2.44% |
SECTORAL ASSET MANAGEMENT INC | 3,623,786 | $54,103,000 | 2.22% |
Lumbard & Kellner, LLC | 81,225 | $1,192,000 | 1.02% |
Artal Group S.A. | 1,300,000 | $19,409,000 | 0.70% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 100,000 | $1,493,000 | 0.48% |
Rhenman & Partners Asset Management AB | 73,702 | $1,100,000 | 0.33% |
PINNACLE ASSOCIATES LTD | 883,647 | $13,193,000 | 0.26% |
FIRST TRUST ADVISORS LP | 3,608,918 | $53,881,000 | 0.24% |
Granahan Investment Management | 540,641 | $8,072,000 | 0.22% |